213 related articles for article (PubMed ID: 32818509)
21. DNA methylation-based classification of sinonasal undifferentiated carcinoma.
Dogan S; Vasudevaraja V; Xu B; Serrano J; Ptashkin RN; Jung HJ; Chiang S; Jungbluth AA; Cohen MA; Ganly I; Berger MF; Momeni Boroujeni A; Ghossein RA; Ladanyi M; Chute DJ; Snuderl M
Mod Pathol; 2019 Oct; 32(10):1447-1459. PubMed ID: 31186531
[TBL] [Abstract][Full Text] [Related]
22. SMARCB1/INI1-deficient epithelioid and myxoid neoplasms in paratesticular region: Expanding the clinicopathologic and molecular spectrum.
Yin X; Yang X; Wang S; Zhou J; Zhao M
Ann Diagn Pathol; 2024 Feb; 68():152242. PubMed ID: 38039617
[TBL] [Abstract][Full Text] [Related]
23. Genomic and Immunologic Characterization of INI1-Deficient Pediatric Cancers.
Forrest SJ; Al-Ibraheemi A; Doan D; Ward A; Clinton CM; Putra J; Pinches RS; Kadoch C; Chi SN; DuBois SG; Leavey PJ; LeBoeuf NR; Mullen E; Collins N; Church AJ; Janeway KA
Clin Cancer Res; 2020 Jun; 26(12):2882-2890. PubMed ID: 32122923
[TBL] [Abstract][Full Text] [Related]
24. Vulvar Yolk Sac Tumors Are Somatically Derived SMARCB1 (INI-1)-Deficient Neoplasms.
Kolin DL; Konstantinopoulos PA; Campos SM; Toumi G; Kolahi KA; Gars EJ; Howitt BE
Am J Surg Pathol; 2022 Feb; 46(2):169-178. PubMed ID: 34265804
[TBL] [Abstract][Full Text] [Related]
25. Recurrent SMARCB1 Inactivation in Epithelioid Malignant Peripheral Nerve Sheath Tumors.
Schaefer IM; Dong F; Garcia EP; Fletcher CDM; Jo VY
Am J Surg Pathol; 2019 Jun; 43(6):835-843. PubMed ID: 30864974
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression in SMARCB1/INI1-deficient sinonasal carcinoma: a clinicopathological and molecular genetic study.
Laco J; Kovaříková H; Chmelařová M; Vošmiková H; Sieglová K; Baranová I; Dundr P; Němejcová K; Michálek J; Šatanková J; Vošmik M; Ryška A
Virchows Arch; 2018 May; 472(5):871-875. PubMed ID: 29327137
[No Abstract] [Full Text] [Related]
27. SMARCB1-Deficient Sinonasal Carcinoma: Systematic Review and Case Report.
Parsel SM; Jawad BA; McCoul ED
World Neurosurg; 2020 Apr; 136():305-310. PubMed ID: 32001406
[TBL] [Abstract][Full Text] [Related]
28. [Clinical and pathological analysis of 2 cases of
Chen ZW; Fang SG; Ren JQ; Qian LJ; Shi HQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):400-402. PubMed ID: 32306640
[TBL] [Abstract][Full Text] [Related]
29. SMARCB1 (INI1)-Deficient Sinonasal Carcinoma with Yolk Sac differentiation Showing Co-loss of SMARCA4 Immunostaining - A Case Report and Literature Review.
Ng JKM; Chan JYK; Li JJX; Tang K; Yeung DCM; Chan ABW
Head Neck Pathol; 2022 Sep; 16(3):934-941. PubMed ID: 35257325
[TBL] [Abstract][Full Text] [Related]
30. INI1 (SMARCB1)-Deficient Sinonasal Carcinoma: A Clinicopathologic Report of 2 Cases.
Wasserman JK; Dickson BC; Perez-Ordonez B; de Almeida JR; Irish JC; Weinreb I
Head Neck Pathol; 2017 Jun; 11(2):256-261. PubMed ID: 27644951
[TBL] [Abstract][Full Text] [Related]
31. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms.
Dermawan JK; Singer S; Tap WD; Nacev BA; Chi P; Wexler LH; Ortiz MV; Gounder M; Antonescu CR
Mod Pathol; 2022 Dec; 35(12):1900-1909. PubMed ID: 36088476
[TBL] [Abstract][Full Text] [Related]
32. SMARCB1 (INI1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
Fuoco J; Huang M; Esfandiari N; MacMillan C; Ali A; Dave K; Freilich M; Magalhaes M
Head Neck; 2024 Mar; 46(3):E32-E39. PubMed ID: 38088461
[TBL] [Abstract][Full Text] [Related]
33. SMARCB1/INI1-deficient tumors of adulthood.
Parker NA; Al-Obaidi A; Deutsch JM
F1000Res; 2020; 9():662. PubMed ID: 33796273
[TBL] [Abstract][Full Text] [Related]
34. Primary cutaneous SMARCB1-deficient carcinoma.
Hui Y; Cotzia P; Rana S; Kezlarian BE; Lin O; Hollmann TJ; Dogan S
J Cutan Pathol; 2021 Aug; 48(8):1051-1060. PubMed ID: 33625734
[TBL] [Abstract][Full Text] [Related]
35. Recurrent loss of chromosome 22 and SMARCB1 deletion in extra-axial chordoma: A clinicopathological and molecular analysis.
Wen X; Cimera R; Aryeequaye R; Abhinta M; Athanasian E; Healey J; Fabbri N; Boland P; Zhang Y; Hameed M
Genes Chromosomes Cancer; 2021 Dec; 60(12):796-807. PubMed ID: 34392582
[TBL] [Abstract][Full Text] [Related]
36. SMARCB1-Deficient Sinonasal Carcinoma: A Case Report and Discussion of the Clinical Implications.
Trieu V; Aulet RM; Ciolino A; Rimash T
Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):676-680. PubMed ID: 30873845
[TBL] [Abstract][Full Text] [Related]
37. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
[TBL] [Abstract][Full Text] [Related]
38. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.
Contrera KJ; Shakibai N; Su SY; Gule-Monroe MK; Roberts D; Brahimaj B; Williams MD; Ferrarotto R; Phan J; Gunn B; Raza S; DeMonte F; Hanna EY
Otolaryngol Head Neck Surg; 2023 Aug; 169(2):435-440. PubMed ID: 36856048
[TBL] [Abstract][Full Text] [Related]
39. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas.
Dogan S; Chute DJ; Xu B; Ptashkin RN; Chandramohan R; Casanova-Murphy J; Nafa K; Bishop JA; Chiosea SI; Stelow EB; Ganly I; Pfister DG; Katabi N; Ghossein RA; Berger MF
J Pathol; 2017 Aug; 242(4):400-408. PubMed ID: 28493366
[TBL] [Abstract][Full Text] [Related]
40. INI1-Deficient Thyroid Carcinoma is an Aggressive Disease with Epithelioid and Rhabdoid Phenotype. A Case Report, Survey of INI1 Expression in Thyroid Lesions and Literature Review.
Liu Z; Seshadri M; Gupta V; Papanicolau-Sengos A; Merzianu M
Head Neck Pathol; 2021 Dec; 15(4):1246-1252. PubMed ID: 34057693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
